Role of Angiotensin II in Injury-Induced Neointima Formation in Rats
Angiotensin converting enzyme inhibition markedly suppresses neointima formation in response to balloon catheter-induced vascular injury of the rat carotid artery. To determine whether this effect was mediated through the vasoactive peptide angiotensin II (Ang II), two approaches were followed. Firs...
Gespeichert in:
Veröffentlicht in: | Hypertension (Dallas, Tex. 1979) Tex. 1979), 1991-10, Vol.18 (4 Suppl II), p.II-60-II-64 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | II-64 |
---|---|
container_issue | 4 Suppl II |
container_start_page | II-60 |
container_title | Hypertension (Dallas, Tex. 1979) |
container_volume | 18 |
creator | Osterrieder, Wolfgang Miiller, Rita K.M Powell, Jerry S Clozel, Jean-Paul Hefti, Fridolin Baumgartner, Hans R |
description | Angiotensin converting enzyme inhibition markedly suppresses neointima formation in response to balloon catheter-induced vascular injury of the rat carotid artery. To determine whether this effect was mediated through the vasoactive peptide angiotensin II (Ang II), two approaches were followed. First, the balloon model was used to compare the effects of continuous infusion of Ang II, with and without concurrent converting enzyme inhibition by cilazapril; second, the effects of the orally active nonpeptidic Ang II receptor antagonist DuP 753 were analyzed. Morphometric analysis was performed at 14 days after balloon injury. Animals that received continuous infusion of Ang II (0.3 μ/min/rat) were found to have significantly greater neointima formation in response to balloon injury than controls. Animals treated with cilazapril (10 mg/kg/day) had markedly reduced neointima formation, but in animals receiving infusion of Ang II, treatment with cilazapril did not suppress development of neointimal lesions. In the second group of experiments, DuP 753 (10 mg/kg twice daily) was as effective to prevent neointima formation as cilazapril. These data sapport the conclusions that converting enzyme inhibition prevents neointima formation after vascular injury through inhibition of Ang II generation. |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_72132281</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>72132281</sourcerecordid><originalsourceid>FETCH-LOGICAL-p1831-6d0ca8fc4bc9d6b50e254607249c204238b0f3d879138b7a9b12a4fd9e7be9a13</originalsourceid><addsrcrecordid>eNotUF1LwzAUDaLMOf0JQp98C-SrH3kc02lhKAwF30ra3LrONJlJy9i_N2W7D-feyzmc-3GF5jRlAos049doTqgUWFL6fYvuQtgTQoUQ-QzNaME5Z-kcPW-dgcS1ydL-dG4AGzqblGUyod2P_oRLq8cGdPIOrrND16tk7Xyvhs7ZSbVVQ7hHN60yAR4ueYG-1i-fqze8-XgtV8sNPsR5FGeaNKpoG1E3Umd1SoClIiM5E7JhRDBe1KTlusgljWWuZE2ZEq2WkNcgFeUL9HT2PXj3N0IYqr4LDRijLLgxVDmjnLFiEj5ehGPdg64OPu7tT9Xl7MiLM390ZgAffs14BF_tQJlhV5EYgmUFpjL-LjYUT0D5P5UsYuQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72132281</pqid></control><display><type>article</type><title>Role of Angiotensin II in Injury-Induced Neointima Formation in Rats</title><source>MEDLINE</source><source>American Heart Association Journals</source><source>Journals@Ovid Complete - AutoHoldings</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Osterrieder, Wolfgang ; Miiller, Rita K.M ; Powell, Jerry S ; Clozel, Jean-Paul ; Hefti, Fridolin ; Baumgartner, Hans R</creator><creatorcontrib>Osterrieder, Wolfgang ; Miiller, Rita K.M ; Powell, Jerry S ; Clozel, Jean-Paul ; Hefti, Fridolin ; Baumgartner, Hans R</creatorcontrib><description>Angiotensin converting enzyme inhibition markedly suppresses neointima formation in response to balloon catheter-induced vascular injury of the rat carotid artery. To determine whether this effect was mediated through the vasoactive peptide angiotensin II (Ang II), two approaches were followed. First, the balloon model was used to compare the effects of continuous infusion of Ang II, with and without concurrent converting enzyme inhibition by cilazapril; second, the effects of the orally active nonpeptidic Ang II receptor antagonist DuP 753 were analyzed. Morphometric analysis was performed at 14 days after balloon injury. Animals that received continuous infusion of Ang II (0.3 μ/min/rat) were found to have significantly greater neointima formation in response to balloon injury than controls. Animals treated with cilazapril (10 mg/kg/day) had markedly reduced neointima formation, but in animals receiving infusion of Ang II, treatment with cilazapril did not suppress development of neointimal lesions. In the second group of experiments, DuP 753 (10 mg/kg twice daily) was as effective to prevent neointima formation as cilazapril. These data sapport the conclusions that converting enzyme inhibition prevents neointima formation after vascular injury through inhibition of Ang II generation.</description><identifier>ISSN: 0194-911X</identifier><identifier>EISSN: 1524-4563</identifier><identifier>PMID: 1833325</identifier><language>eng</language><publisher>United States: American Heart Association, Inc</publisher><subject>Angiotensin II - physiology ; Angiotensin-Converting Enzyme Inhibitors - pharmacology ; Animals ; Biphenyl Compounds - pharmacology ; Carotid Arteries - drug effects ; Carotid Arteries - pathology ; Cell Division - drug effects ; Cilazapril ; Endothelium, Vascular - drug effects ; Endothelium, Vascular - pathology ; Endothelium, Vascular - physiology ; Imidazoles - pharmacology ; Losartan ; Male ; Pyridazines - pharmacology ; Rats ; Regeneration - drug effects ; Tetrazoles - pharmacology</subject><ispartof>Hypertension (Dallas, Tex. 1979), 1991-10, Vol.18 (4 Suppl II), p.II-60-II-64</ispartof><rights>1991 American Heart Association, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1833325$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Osterrieder, Wolfgang</creatorcontrib><creatorcontrib>Miiller, Rita K.M</creatorcontrib><creatorcontrib>Powell, Jerry S</creatorcontrib><creatorcontrib>Clozel, Jean-Paul</creatorcontrib><creatorcontrib>Hefti, Fridolin</creatorcontrib><creatorcontrib>Baumgartner, Hans R</creatorcontrib><title>Role of Angiotensin II in Injury-Induced Neointima Formation in Rats</title><title>Hypertension (Dallas, Tex. 1979)</title><addtitle>Hypertension</addtitle><description>Angiotensin converting enzyme inhibition markedly suppresses neointima formation in response to balloon catheter-induced vascular injury of the rat carotid artery. To determine whether this effect was mediated through the vasoactive peptide angiotensin II (Ang II), two approaches were followed. First, the balloon model was used to compare the effects of continuous infusion of Ang II, with and without concurrent converting enzyme inhibition by cilazapril; second, the effects of the orally active nonpeptidic Ang II receptor antagonist DuP 753 were analyzed. Morphometric analysis was performed at 14 days after balloon injury. Animals that received continuous infusion of Ang II (0.3 μ/min/rat) were found to have significantly greater neointima formation in response to balloon injury than controls. Animals treated with cilazapril (10 mg/kg/day) had markedly reduced neointima formation, but in animals receiving infusion of Ang II, treatment with cilazapril did not suppress development of neointimal lesions. In the second group of experiments, DuP 753 (10 mg/kg twice daily) was as effective to prevent neointima formation as cilazapril. These data sapport the conclusions that converting enzyme inhibition prevents neointima formation after vascular injury through inhibition of Ang II generation.</description><subject>Angiotensin II - physiology</subject><subject>Angiotensin-Converting Enzyme Inhibitors - pharmacology</subject><subject>Animals</subject><subject>Biphenyl Compounds - pharmacology</subject><subject>Carotid Arteries - drug effects</subject><subject>Carotid Arteries - pathology</subject><subject>Cell Division - drug effects</subject><subject>Cilazapril</subject><subject>Endothelium, Vascular - drug effects</subject><subject>Endothelium, Vascular - pathology</subject><subject>Endothelium, Vascular - physiology</subject><subject>Imidazoles - pharmacology</subject><subject>Losartan</subject><subject>Male</subject><subject>Pyridazines - pharmacology</subject><subject>Rats</subject><subject>Regeneration - drug effects</subject><subject>Tetrazoles - pharmacology</subject><issn>0194-911X</issn><issn>1524-4563</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1991</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNotUF1LwzAUDaLMOf0JQp98C-SrH3kc02lhKAwF30ra3LrONJlJy9i_N2W7D-feyzmc-3GF5jRlAos049doTqgUWFL6fYvuQtgTQoUQ-QzNaME5Z-kcPW-dgcS1ydL-dG4AGzqblGUyod2P_oRLq8cGdPIOrrND16tk7Xyvhs7ZSbVVQ7hHN60yAR4ueYG-1i-fqze8-XgtV8sNPsR5FGeaNKpoG1E3Umd1SoClIiM5E7JhRDBe1KTlusgljWWuZE2ZEq2WkNcgFeUL9HT2PXj3N0IYqr4LDRijLLgxVDmjnLFiEj5ehGPdg64OPu7tT9Xl7MiLM390ZgAffs14BF_tQJlhV5EYgmUFpjL-LjYUT0D5P5UsYuQ</recordid><startdate>199110</startdate><enddate>199110</enddate><creator>Osterrieder, Wolfgang</creator><creator>Miiller, Rita K.M</creator><creator>Powell, Jerry S</creator><creator>Clozel, Jean-Paul</creator><creator>Hefti, Fridolin</creator><creator>Baumgartner, Hans R</creator><general>American Heart Association, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>199110</creationdate><title>Role of Angiotensin II in Injury-Induced Neointima Formation in Rats</title><author>Osterrieder, Wolfgang ; Miiller, Rita K.M ; Powell, Jerry S ; Clozel, Jean-Paul ; Hefti, Fridolin ; Baumgartner, Hans R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p1831-6d0ca8fc4bc9d6b50e254607249c204238b0f3d879138b7a9b12a4fd9e7be9a13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1991</creationdate><topic>Angiotensin II - physiology</topic><topic>Angiotensin-Converting Enzyme Inhibitors - pharmacology</topic><topic>Animals</topic><topic>Biphenyl Compounds - pharmacology</topic><topic>Carotid Arteries - drug effects</topic><topic>Carotid Arteries - pathology</topic><topic>Cell Division - drug effects</topic><topic>Cilazapril</topic><topic>Endothelium, Vascular - drug effects</topic><topic>Endothelium, Vascular - pathology</topic><topic>Endothelium, Vascular - physiology</topic><topic>Imidazoles - pharmacology</topic><topic>Losartan</topic><topic>Male</topic><topic>Pyridazines - pharmacology</topic><topic>Rats</topic><topic>Regeneration - drug effects</topic><topic>Tetrazoles - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Osterrieder, Wolfgang</creatorcontrib><creatorcontrib>Miiller, Rita K.M</creatorcontrib><creatorcontrib>Powell, Jerry S</creatorcontrib><creatorcontrib>Clozel, Jean-Paul</creatorcontrib><creatorcontrib>Hefti, Fridolin</creatorcontrib><creatorcontrib>Baumgartner, Hans R</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Hypertension (Dallas, Tex. 1979)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Osterrieder, Wolfgang</au><au>Miiller, Rita K.M</au><au>Powell, Jerry S</au><au>Clozel, Jean-Paul</au><au>Hefti, Fridolin</au><au>Baumgartner, Hans R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Role of Angiotensin II in Injury-Induced Neointima Formation in Rats</atitle><jtitle>Hypertension (Dallas, Tex. 1979)</jtitle><addtitle>Hypertension</addtitle><date>1991-10</date><risdate>1991</risdate><volume>18</volume><issue>4 Suppl II</issue><spage>II-60</spage><epage>II-64</epage><pages>II-60-II-64</pages><issn>0194-911X</issn><eissn>1524-4563</eissn><abstract>Angiotensin converting enzyme inhibition markedly suppresses neointima formation in response to balloon catheter-induced vascular injury of the rat carotid artery. To determine whether this effect was mediated through the vasoactive peptide angiotensin II (Ang II), two approaches were followed. First, the balloon model was used to compare the effects of continuous infusion of Ang II, with and without concurrent converting enzyme inhibition by cilazapril; second, the effects of the orally active nonpeptidic Ang II receptor antagonist DuP 753 were analyzed. Morphometric analysis was performed at 14 days after balloon injury. Animals that received continuous infusion of Ang II (0.3 μ/min/rat) were found to have significantly greater neointima formation in response to balloon injury than controls. Animals treated with cilazapril (10 mg/kg/day) had markedly reduced neointima formation, but in animals receiving infusion of Ang II, treatment with cilazapril did not suppress development of neointimal lesions. In the second group of experiments, DuP 753 (10 mg/kg twice daily) was as effective to prevent neointima formation as cilazapril. These data sapport the conclusions that converting enzyme inhibition prevents neointima formation after vascular injury through inhibition of Ang II generation.</abstract><cop>United States</cop><pub>American Heart Association, Inc</pub><pmid>1833325</pmid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0194-911X |
ispartof | Hypertension (Dallas, Tex. 1979), 1991-10, Vol.18 (4 Suppl II), p.II-60-II-64 |
issn | 0194-911X 1524-4563 |
language | eng |
recordid | cdi_proquest_miscellaneous_72132281 |
source | MEDLINE; American Heart Association Journals; Journals@Ovid Complete - AutoHoldings; EZB-FREE-00999 freely available EZB journals |
subjects | Angiotensin II - physiology Angiotensin-Converting Enzyme Inhibitors - pharmacology Animals Biphenyl Compounds - pharmacology Carotid Arteries - drug effects Carotid Arteries - pathology Cell Division - drug effects Cilazapril Endothelium, Vascular - drug effects Endothelium, Vascular - pathology Endothelium, Vascular - physiology Imidazoles - pharmacology Losartan Male Pyridazines - pharmacology Rats Regeneration - drug effects Tetrazoles - pharmacology |
title | Role of Angiotensin II in Injury-Induced Neointima Formation in Rats |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T23%3A39%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Role%20of%20Angiotensin%20II%20in%20Injury-Induced%20Neointima%20Formation%20in%20Rats&rft.jtitle=Hypertension%20(Dallas,%20Tex.%201979)&rft.au=Osterrieder,%20Wolfgang&rft.date=1991-10&rft.volume=18&rft.issue=4%20Suppl%20II&rft.spage=II-60&rft.epage=II-64&rft.pages=II-60-II-64&rft.issn=0194-911X&rft.eissn=1524-4563&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E72132281%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72132281&rft_id=info:pmid/1833325&rfr_iscdi=true |